Found 27 hits for monomerid = 427741 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.160 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427741
(US10544143, Example 174 | US10730877, Example 199 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(nc2c1C(C)C)C1CCC(CC1)N1CCCC1 |(9.39,.97,;7.85,.97,;7.08,-.36,;5.54,-.36,;4.77,-1.69,;5.54,-3.03,;7.08,-3.03,;8.11,-4.17,;9.51,-3.55,;9.35,-2.01,;7.85,-1.69,;3.23,-1.69,;2.32,-2.94,;.86,-2.46,;-.48,-3.23,;-1.81,-2.46,;-1.81,-.92,;-.48,-.15,;.86,-.92,;2.32,-.45,;2.72,1.04,;1.63,2.13,;4.21,1.44,;-3.14,-.15,;-4.48,-.92,;-5.81,-.15,;-5.81,1.39,;-4.48,2.16,;-3.14,1.39,;-7.14,2.16,;-7.14,3.7,;-8.61,4.17,;-9.51,2.93,;-8.61,1.68,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)24-25(19-14-23(34-3)27-28-16-29-33(27)15-19)31-22-11-10-21(30-26(22)24)18-6-8-20(9-7-18)32-12-4-5-13-32/h10-11,14-18,20,31H,4-9,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Search and Browse
